Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT03160261
Clinical Trials · NCT03160261
Effect of Exenatide on Cortisol Secretion
Completed
Phase 4
Exenatide
(Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Tartu
Enrollment
10
Start date
Sep 2017
Locations
1 site, Estonia
Primary endpoint
Cortisol peak
View Exenatide compound reference